Cytostatin
Latest Information Update: 28 Oct 1997
At a glance
- Originator Microbial Chemistry Research Foundation
- Class Antineoplastics; Phosphoric acid esters; Pyrones; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Oct 1997 No-Development-Reported for Cancer in Japan (Unknown route)
- 31 Jan 1995 Preclinical development for Cancer in Japan (Unknown route)